These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine. Liang WS; Beaulieu-Jones B; Smalley S; Snyder M; Goetz LH; Schork NJ Front Pharmacol; 2024; 15():1348112. PubMed ID: 38545548 [TBL] [Abstract][Full Text] [Related]
5. Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review. Del Valle-Moreno P; Suarez-Casillas P; Mejías-Trueba M; Ciudad-Gutiérrez P; Guisado-Gil AB; Gil-Navarro MV; Herrera-Hidalgo L Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514045 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring in India: A strength, weakness, opportunity and threats analysis. Pattanaik S; Gota V; Tripathi SK; Kshirsagar NA Br J Clin Pharmacol; 2023 Nov; 89(11):3247-3261. PubMed ID: 37259249 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. van der Kleij MBA; Guchelaar NAD; Mathijssen RHJ; Versluis J; Huitema ADR; Koolen SLW; Steeghs N Clin Pharmacokinet; 2023 Oct; 62(10):1333-1364. PubMed ID: 37584840 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy. Karvaly GB; Vásárhelyi B Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931913 [TBL] [Abstract][Full Text] [Related]
10. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. Doki K; Homma M; Kuga K; Aonuma K; Sakai S; Yamaguchi I; Kohda Y Eur J Clin Pharmacol; 2007 Oct; 63(10):951-7. PubMed ID: 17665182 [TBL] [Abstract][Full Text] [Related]
11. Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia. Doki K; Homma M; Kuga K; Kusano K; Watanabe S; Yamaguchi I; Kohda Y Eur J Clin Pharmacol; 2006 Nov; 62(11):919-26. PubMed ID: 16944116 [TBL] [Abstract][Full Text] [Related]
12. Digoxin therapeutic drug monitoring: an audit and review. Sidwell A; Barclay M; Begg E; Moore G N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536 [TBL] [Abstract][Full Text] [Related]
13. Appropriateness of therapeutic drug monitoring for lithium. Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements. Follath F J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S74-6. PubMed ID: 1723123 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring in cancer chemotherapy. Bach DM; Straseski JA; Clarke W Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218 [TBL] [Abstract][Full Text] [Related]
16. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring. Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999 [TBL] [Abstract][Full Text] [Related]
17. Appropriate dosing regimen of allopurinol in Japanese patients. Takada M; Okada H; Kotake T; Kawato N; Saito M; Nakai M; Gunji T; Shibakawa M J Clin Pharm Ther; 2005 Aug; 30(4):407-12. PubMed ID: 15985055 [TBL] [Abstract][Full Text] [Related]